Navigation Links
New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
Date:10/22/2007

inical studies in humans, were selected by the Institute's distinguished Peer Review Committee because of their unique and potentially groundbreaking nature. The committee seeks the best new science and the widest possible scope of ideas. While high-risk in many cases, the studies are also ripe with promise for cracking the mysteries of a disorder that devastates more than 1.5 million Americans, and millions more worldwide. No new treatment for lupus has been approved in nearly 50 years, and current therapies can be toxic.

The LRI encourages grant applications from such diverse disciplines as genetics, immunology, cardiology, and neurology, and from both experienced scientists and new investigators. Some recipients may never have worked in lupus, but their hypotheses have the potential to shed light on the mysteries of this disabling disease. Several of the 2007 grant recipients, for example, are investigating potential lupus biomarkers ("early markers" or "predictors" of disease and treatments) that might help diagnose, monitor, and treat lupus more successfully than current tests do. Altogether, the LRI has made possible the investigation of more than 20 potential biomarkers, 6 of which are already being tested in people.

"These 2007 research grants are of exceptional interest and quality, and will likely lead to important advances in lupus," said David S. Pisetsky, MD, PhD, co-chair of the LRI Peer Review Task Force and chief of the Division of Rheumatology and Immunology at Duke University Medical Center. "By building on recent findings in basic research, especially in immunology, on the mechanisms underlying the origin and development of lupus, they may well lead to improved care and treatment for people with this difficult illness."

Top lupus scientists from government and academia on the Institute's Peer Review Task Force rigorously evaluate the submissions. Dr. Pisetsky co- chaired the 2007 Task Force with Mark Shlomchik, MD, PhD, professor
'/>"/>

SOURCE The Lupus Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Miracle cure for Alzheimer’s around the corner
2. Immune cells halt round in space
3. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
4. Art of Living concept expanding around the globe
5. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
6. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
7. The Looming Controversy Surrounding Facial Transplant
8. Surroundings Have An Effect On Weight
9. Death Wishes Influenced By Ethnicity and Racial Background
10. Labs around the World to Join Hands to Detect Bird Flu
11. Chicken takes a walk round the country side !
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)... The Accreditation Council for Continuing Medical ...on of the College of American Pathologists (CAP) t...provider of continuing medical education for physi...PRWEB) August 28, 2008 -- The Accreditation Counci...rded the Education Division of the www.cap.org [...
(Date:8/28/2008)... Leading personal injury law firm files notice of ...olice Department. , Mineo...esandersfirm.com/attorney.asp?attorneyid=14 [Marc...sonal injury law firm of Sanders, Sanders, Block, ...York, today announced that his firm has filed a No...
(Date:8/27/2008)...g. 27 /PRNewswire-FirstCall/ -- Replidyne, Inc.,(N...f its operations reducing,its current employee hea...ons that are scheduled to take place during Septem...tions Replidyne will suspend further,development a...r the,treatment of Clostridium difficile (C. diffi...
(Date:8/27/2008)...revention experts have long known that teens are l... while driving. Now, researchers from the Meharry-...e discovered lack of seat belt use by teen passeng...t ever direct comparison of the differences betwee...lly representative teen population, the Meharry re...
Breaking Medicine News(10 mins):Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Replidyne Announces Restructuring of Operations 2Health News:Teens making poor choices when it comes to riding in vehicles 2
...rogative of choice. They seem to be partial to mid...gy Neurosurgery and Psychiatry suggests that // Fa...ptions to middle aged women with headache as compa...normally spur the patients to a doctor and account...
...Newcastle's Royal Victoria Infirmary was accused o...d from Denton Burn, Newcastle. // She was struck o...gainst her were all proved. A hearing at the Nursi...he said that she was too ill to attend the hearing...
...ve formulated a combination of drugs that could wa...long time that new borns did not feel any pain. //...nt research. The problem was how to stop this pain...n of infants. Principal investigator Anna Taddio...
...me the rage of dance lovers in discos has been fou.../ Ecstasy was first synthesised in 1910. It was p...k Pharmaceuticals as an appetite suppressant. The...loud music exacerbates the effects of ecstasy on t...
Other Medicine News:Health News:The effects of Ecstasy more pronounced in presence of music 2
(Date:8/26/2008)...ambridge Research &,Instrumentation, Inc. (CRi) an...Imaging System. The new system incorporates CRi,s ...ntry-level instrument of choice for in,vivo fluore...cgi-bin/prnh/20080826/NETU054 ), FLEX technology...que,solid-state tunable optics that for the first ...
(Date:8/26/2008)...Corporation today announced the,publication of the...g,OMS103HP in arthroscopic anterior cruciate ligam...nvestigational drug product that is added to,arthr...rove postoperative,knee function and motion, reduc... return to work. The article titled "Novel Drug Pr...
(Date:8/25/2008)...ire/ -- Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assi...for,the benefit of creditors, announced today that...sold at a sealed bid auction on October 10,2008.,...vodopa-Carbidopa that,is the current gold standard...les estimated at approximately $250 million. Signi...
(Date:8/25/2008)...d Japanese Development Studies ...25 /- Genmab has,announced ...ic lymphocytic,leukemia and non-Hodgkin,s lymphoma... begin four studies of,ofatumumab in chronic lymph... lymphoma (NHL) this year., "Genmab and GSK have ...
Breaking Medicine Technology:CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 10731 1FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 10731 2Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 1Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 2Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 3Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 4Observational Data Show Transfusion Patterns in Chemotherapy Induced Anemia Patients Receiving Erythropoiesis Stimulating Agents 1299 5Webcast Alert 3A Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 10728 1Webcast Alert 3A Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 10728 2MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical 10723 1MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical 10723 2
...Pancreatic Enzyme Replacement Therapy Significantl...inical Trials, MILAN, Italy and DAYTON, Ohio, Apri...lty pharmaceutical company, today unveiled,data fr...ct,candidate, Zentase(TM), formerly EUR-1008, for ... (EPI). The US Food and Drug,Administration (FDA) ...
... Presented at the XXI Congress of the Internationa... FRANCISCO, Calif., April 04, 2007 /PRNewswire/ --...t it has received,positive results from EXPERT, a ...T054021, for the prevention of venous,thromboembol...urgery. Based on these results, Portola will advan...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 2Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: